Literature DB >> 17041808

[Cytochrom-P450 mediated drug interactions caused by antibiotics].

Christiane Thallinger1, Christian Joukhadar.   

Abstract

This review focuses on drug interactions with commonly prescribed antibiotics. With each drug coadministered, the likelihood of an adverse interaction increases exponentially. Thus, poly-pharmacotherapy possesses important clinical challenges for clinicians and exposes patients to potentially life-threatening risks. In particular, following co-administration of drugs such as tricyclic antidepressants, anticoagulants and antiarrhythmics, which are characterized by narrow therapeutic windows, even small changes in plasma levels can cause serious adverse reactions and/or therapeutic failure. The hepatic and intestinal cytochrome, or CYP-450 enzyme system is responsible for the biotransformation of a multitude of drugs and is frequently involved in drug interactions. The present review therefore presents a comprehensive overview on potential drug interactions with antibiotics, which are mediated by the cytochrome-P450-enzymes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041808     DOI: 10.1007/s10354-006-0336-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  53 in total

1.  Pharmacokinetic interaction of clozapine and rifampicin in a forensic patient with an atypical mycobacterial infection.

Authors:  A A Joos; U G Frank; W P Kaschka
Journal:  J Clin Psychopharmacol       Date:  1998-02       Impact factor: 3.153

2.  Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.

Authors:  Z Desta; N V Soukhova; D A Flockhart
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 3.  Macrolide drug interactions: an update.

Authors:  M P Pai; D M Graci; G W Amsden
Journal:  Ann Pharmacother       Date:  2000-04       Impact factor: 3.154

Review 4.  Use of sulfonylurea agents in older diabetic patients.

Authors:  A L Peters; M B Davidson
Journal:  Clin Geriatr Med       Date:  1990-11       Impact factor: 3.076

Review 5.  Update on rifampin drug interactions. II.

Authors:  S M Borcherding; A M Baciewicz; T H Self
Journal:  Arch Intern Med       Date:  1992-04

Review 6.  Rifampin and rifabutin drug interactions: an update.

Authors:  Christopher K Finch; Cary R Chrisman; Anne M Baciewicz; Timothy H Self
Journal:  Arch Intern Med       Date:  2002-05-13

Review 7.  Drug-induced hepatotoxicity: 2005.

Authors:  Willis C Maddrey
Journal:  J Clin Gastroenterol       Date:  2005-04       Impact factor: 3.062

8.  Acetaminophen hepatotoxicity: potentiation by isoniazid.

Authors:  J S Crippin
Journal:  Am J Gastroenterol       Date:  1993-04       Impact factor: 10.864

9.  Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide.

Authors:  Lauri I Kajosaari; Mikko Niemi; Janne T Backman; Pertti J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  2006-02-07       Impact factor: 6.875

Review 10.  Pharmacokinetic drug interactions of macrolides.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.